MSB 2.51% 97.0¢ mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-32

  1. 405 Posts.
    lightbulb Created with Sketch. 39
    Yassss! Wonderful news
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.